v3.26.1
Leases - Additional Information (Details) - USD ($)
 1 Months Ended 3 Months Ended
Apr. 30, 2026
Mar. 31, 2026
Lessee, Lease, Description [Line Items]    
Lease not yet commenced   As of March 31, 2026, the Company has one lease in China which has not yet commenced or been recognized, since the facility is not yet available for the Company’s use.
Fixed lease payments   $ 1,300,000
Initial term of the lease   5 years
Future minimum lease payments   $ 46,979,000
Future minimum lease payments due in next 12 months   $ 5,697,000
New Operating Lease Facility    
Lessee, Lease, Description [Line Items]    
Operating lease description   In November 2021, the Company entered into a noncancelable operating lease for its current headquarters. The lease, as amended, commenced in January 2022 and expires in January 2034. A portion of the facility was subleased to Attovia Therapeutics, Inc. (“Attovia”), a related party, through March 2025.
Lease for Manufacturing, Research and Office Space in Fremont, California | Subsequent Event    
Lessee, Lease, Description [Line Items]    
Initial term of the lease 159 months  
Future minimum lease payments due in next 12 months $ 0  
Maximum | Lease for Manufacturing, Research and Office Space in Fremont, California | Subsequent Event    
Lessee, Lease, Description [Line Items]    
Tenant improvement allowances receivable 7,500,000  
Future minimum lease payments $ 33,900,000